Viewing StudyNCT03595592



Ignite Creation Date: 2024-05-06 @ 11:46 AM
Last Modification Date: 2024-10-26 @ 12:49 PM
Study NCT ID: NCT03595592
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-06
First Post: 2018-07-11

Brief Title: Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
Sponsor: Fondazione Michelangelo
Organization: Fondazione Michelangelo

Conditions & Keywords Data

Conditions:
Name
Invasive Breast Cancer
Keywords:
Name View
Unilateral HER2 positive View